The survival of differentiating embryonic stem cells is dependent on the SCF-KIT pathway.
Taylor, A Helen
Whetton, Anthony D
Forrester, Lesley M
AffiliationJohn Hughes Bennett Laboratory, Edinburgh Cancer Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK.
MetadataShow full item record
AbstractThe stem cell factor (SCF)-KIT signal transduction pathway plays a role in the proliferation, differentiation and survival of a range of stem and progenitor cell types but little is known about its function in embryonic stem (ES) cells. We generated ES cells carrying a null allele of Kit as well as a knock-in allele that encodes an SCF-independent hybrid KIT receptor that can be activated by the FKBP binding drug, AP20187. KIT null ES cells die when induced to differentiate upon withdrawal of leukaemia inhibitory factor in monolayer culture. This phenotype is recapitulated in wild-type ES cells treated with a KIT-neutralising antibody and reversed in mutant cells by activation of the hybrid KIT receptor. Differentiating KIT null ES cells exhibit elevated levels of DNA laddering and reduced BCL2 expression, indicative of apoptosis. We conclude that mouse ES cell differentiation in vitro is dependent on the SCF-KIT pathway contrasting with the apparently normal differentiation of KIT null inner cell mass or epiblast cells in vivo. This discrepancy could be explained by the presence of compensatory signals in the embryo or it could lend support to the idea of a phenotypic relationship between ES cells and early germ cells.
CitationThe survival of differentiating embryonic stem cells is dependent on the SCF-KIT pathway. 2006, 119 (Pt 15):3039-46 J. Cell. Sci.
JournalJournal of Cell Science
- Proliferation and differentiation of spermatogonial stem cells in the w/wv mutant mouse testis.
- Authors: Ohta H, Tohda A, Nishimune Y
- Issue date: 2003 Dec
- SCF/KIT inhibition has a cumulative but reversible effect on the self-renewal of embryonic stem cells and on the survival of differentiating cells.
- Authors: Fraser L, Taylor AH, Forrester LM
- Issue date: 2013 Aug
- c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells.
- Authors: Ricotti E, Fagioli F, Garelli E, Linari C, Crescenzio N, Horenstein AL, Pistamiglio P, Vai S, Berger M, di Montezemolo LC, Madon E, Basso G
- Issue date: 1998 Apr 1
- Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
- Authors: Young SM, Cambareri AC, Odell A, Geary SM, Ashman LK
- Issue date: 2007 Dec
- Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
- Authors: Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ
- Issue date: 2007 Mar